ConductScience.org, home

Paper · 28536403

Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes.

Sala V and 5 others. Biomedicines, 2015. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes. Papers, record 28536403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28536403

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes.
PubMed
Journal
Biomedicines
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.07
iCite
Revised in PubMed
2020-09-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sala VValentina
2Gallo SSimona
3Gatti SStefano
4Vigna EElisa
5Ponzetto AAntonio
6Crepaldi TTiziana

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18,698,236Differential splicing-in of a proline-rich exon converts alphaNAC into a muscle-specific transcription factor.Genes Dev1996https://conductscience.org/library/papers/8698236PubMed
29,473,336HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells.Dev Biol1998https://conductscience.org/library/papers/9473336PubMed
31,319,065Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1319065PubMed
48,288,123bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out.Genes Dev1994https://conductscience.org/library/papers/8288123PubMed
59,097,022Chemotaxis of skeletal muscle satellite cells.Dev Dyn1997https://conductscience.org/library/papers/9097022PubMed
69,551,084Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation.Biochim Biophys Acta1998https://conductscience.org/library/papers/9551084PubMed
724,870,234mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert).Nature2014https://conductscience.org/library/papers/24870234PubMed
89,398,440Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells.Dev Biol1997https://conductscience.org/library/papers/9398440PubMed
917,194,700Conditional activation of MET in differentiated skeletal muscle induces atrophy.J Biol Chem2007https://conductscience.org/library/papers/17194700PubMed
1010,825,239Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27.J Cell Physiol2000https://conductscience.org/library/papers/10825239PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
37,985,931Age-related nitration/dysfunction of myogenic stem cell activator HGF.Aging Cell2024https://conductscience.org/library/papers/37985931

Source PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SLTM79,811PubTator's text mininghttps://conductscience.org/library/genes/79811

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28536403

GET https://conductscience.org/api/papers/v1/28536403/references?page=2